Literature DB >> 23578927

HECT-E3 ligase ETC-1 regulates securin and cyclin B1 cytoplasmic abundance to promote timely anaphase during meiosis in C. elegans.

Ruishan Wang1, Zeenia Kaul, Charuta Ambardekar, Takaharu G Yamamoto, Kanisha Kavdia, Kiran Kodali, Anthony A High, Risa Kitagawa.   

Abstract

The anaphase inhibitor securin plays a crucial role in regulating the timing of sister chromatid separation during mitosis. When sister chromatid pairs become bioriented, the E3 ligase anaphase promoting complex/cyclosome (APC/C) ubiquitylates securin for proteolysis, triggering sister chromatid separation. Securin is also implicated in regulating meiotic progression. Securin protein levels change sharply during cell cycle progression, enabling its timely action. To understand the mechanism underlying the tightly regulated dynamics of securin, we analyzed the subcellular localization of the securin IFY-1 during C. elegans development. IFY-1 was highly expressed in the cytoplasm of germ cells. The cytoplasmic level of IFY-1 declined immediately following meiosis I division and remained low during meiosis II and following mitoses. We identified a C. elegans homolog of another type of E3 ligase, UBE3C, designated ETC-1, as a regulator of the cytoplasmic IFY-1 level. RNAi-mediated depletion of ETC-1 stabilized IFY-1 and CYB-1 (cyclin B1) in post-meiosis I embryos. ETC-1 knockdown in a reduced APC function background caused an embryonic lethal phenotype. In vitro, ETC-1 ubiquitylates IFY-1 and CYB-1 in the presence of the E2 enzyme UBC-18, which functions in pharyngeal development. Genetic analysis revealed that UBC-18 plays a distinct role together with ETC-1 in regulating the cytoplasmic level of IFY-1 during meiosis. Our study reports a novel mechanism, mediated by ETC-1, that co-operates with APC/C to maintain the meiotic arrest required for proper cell cycle timing during reproduction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23578927     DOI: 10.1242/dev.090688

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  7 in total

1.  Cyclin CYB-3 controls both S-phase and mitosis and is asymmetrically distributed in the early C. elegans embryo.

Authors:  W Matthew Michael
Journal:  Development       Date:  2016-09-01       Impact factor: 6.868

2.  Involvement of HECT-type E3 ubiquitin ligase genes in salt chemotaxis learning in Caenorhabditis elegans.

Authors:  Yasuaki Ike; Masahiro Tomioka; Yuichi Iino
Journal:  Genetics       Date:  2022-04-04       Impact factor: 4.562

3.  Ubiquitin ligases and a processive proteasome facilitate protein clearance during the oocyte-to-embryo transition in Caenorhabditis elegans.

Authors:  Caroline A Spike; Tatsuya Tsukamoto; David Greenstein
Journal:  Genetics       Date:  2022-05-05       Impact factor: 4.402

4.  Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation.

Authors:  Maiko Okada; Fumiaki Ohtake; Hiroyuki Nishikawa; Wenwen Wu; Yasushi Saeki; Keiji Takana; Tomohiko Ohta
Journal:  Mol Endocrinol       Date:  2015-09-21

5.  Kinetochore-localized BUB-1/BUB-3 complex promotes anaphase onset in C. elegans.

Authors:  Taekyung Kim; Mark W Moyle; Pablo Lara-Gonzalez; Christian De Groot; Karen Oegema; Arshad Desai
Journal:  J Cell Biol       Date:  2015-05-18       Impact factor: 10.539

6.  The ubiquitin ligase CRL2ZYG11 targets cyclin B1 for degradation in a conserved pathway that facilitates mitotic slippage.

Authors:  Riju S Balachandran; Cassandra S Heighington; Natalia G Starostina; James W Anderson; David L Owen; Srividya Vasudevan; Edward T Kipreos
Journal:  J Cell Biol       Date:  2016-10-17       Impact factor: 10.539

7.  BUB-1 targets PP2A:B56 to regulate chromosome congression during meiosis I in C. elegans oocytes.

Authors:  Laura Bel Borja; Flavie Soubigou; Samuel J P Taylor; Conchita Fraguas Bringas; Jacqueline Budrewicz; Pablo Lara-Gonzalez; Christopher G Sorensen Turpin; Joshua N Bembenek; Dhanya K Cheerambathur; Federico Pelisch
Journal:  Elife       Date:  2020-12-23       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.